Myungmoon Pharm executive Jung Joon Il raises stake to 0.80% from 0.80% after buying 3,000 shares
Bitget2026/10/06 01:19Myungmoon Pharm executive Jung Joon Il raised his common-share holding to 273,000 shares from 270,000. The stake remained 0.80% of outstanding shares as of Oct. 6, 2026. The change reflected an on-market purchase of 3,000 shares at KRW 1,230 per share. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Myungmoon Pharm. Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261006000035), on October 06, 2026, and is solely responsible for the information contained therein.
- Myungmoon Pharm executive Jung Joon Il raised his common-share holding to 273,000 shares from 270,000.
- The stake remained 0.80% of outstanding shares as of Oct. 6, 2026.
- The change reflected an on-market purchase of 3,000 shares at KRW 1,230 per share.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

SoftBank develops contingency plans for slowdown in US data center business, considers shifting to other countries
A new twist has emerged in the US AI data center investment boom. SoftBank is preparing for cooling US demand and a deteriorating political environment, and does not rule out shifting data center construction priorities to other countries. As cross-border computing power delivery capability improves and investment returns come under question, the logic behind AI infrastructure expansion is loosening, and over $3.5 trillion in infrastructure investment now faces potential impairment risks.

Quantumrail Cancels 10 Billion Won Convertible Bond Offering